Sprague-Dawley rats, using 1,2-dimethylhydrazine (DMH) as described previously (Druckrey et al., 1967; Tutton and Barkla, 1976) . Tumour-bearing animals were given i.p. injections of either cyproheptadine (Merk Sharp & Dohme (Australia) Pty. Ltd, 1 mg/kg, 3 rats) or methysergide (Sandoz Australia Pty. Ltd, 0.1 mg/kg, 3 rats) and killed 15 h later by decapitation.
The doses used are similar to those reported previously as producing pharmacological blockade of peripheral 5HT receptors (Baumgarten et al., 1972) . Whilst the treatment duration for maximum effect has yet to be determined, 15 h Accepted 14 July 1977 was chosen as being a suitable time for identification of acutely necrotic cells in situ before possible phagocytosis or loss of necrotic cells into the intestinal lumen.
Specimens of descending colon and tumours of transverse or descending colon were prepared for light microscopic examination as described previously (Tutton and Barkla, 1976) . Corresponding tissues from 4 tumour-bearing rats not treated with 5HT-antagonists were also prepared for light microscopy and served as controls. For electron microscopy, specimens of descending colon and tumours of transverse or descending colon were taken from experimental animals killed at 1 and 2 h after treatment with either cyproheptadine or methysergide, and prepared for electron microscopy as described previously (Barkla and Tutton, 1977) . Corresponding tissues from untreated tumour-bearing rats were also prepared for electron microscopy using the same methods and served as controls. Histological sections of all tumours were examined initially at X 125 magnification, and those few tumours showing a histological organization other than well differentiated adenocarcinomas were discarded from the study.
Estimation of necrotic and non-necrotic cell numbers in histological sections of both control and experimental animals were made in the following way. Sections of tumours were examined at X 400 magnification and the numbers of necrotic and non-necrotic cells per visual field were counted using an eyepiece with a No changes in morphology were observed using light or electron microscopy of sections of non-malignant colonic epithelium adjacent to tumours taken from treated animals. The cytotoxicity reported here of two 5HT antagonists (cyproheptadine and methysergide) in DMH-induced colonic carcinomas, when considered with our previous observation that a toxic congener of 5HT (5,6-DHT) is also cytotoxic to DHM-induced colonic carcinomas (Tutton and Barkla, 1977a) , suggests that 5HT-related compounds have a possible role in the chemotherapy of colonic tumours.
The mechanism for the cytotoxicity observed in the present study is unclear. Although 5,6 DHT is a potent vasoconstrictor (Baumgarten et al., 1972) and the tumour necrosis previously observed following injections of 5,6 DHT (Tutton and Barkla, 1977a ) could possibly be explained as an event secondary to vasospasm, both cyproheptadine and methysergide, which were used in the current study, have been reported to inhibit vasoconstriction (Gilbert and Goldberg, 1975; Antonaccio and Cote, 1976) and consequently vasospasm per se seems an inadequate explanation for the tumour necrosis observed.
Further investigations into cytotoxicity of 5HT-related compounds in both DMH-induced colonic carcinomas and in human colonic carcinomas xenografted to immune deficient mice are proceeding. In addition, current experiments are investigating the effects of these drugs upon tumour-cell division, and also the cytotoxicity of these drugs both at different dose levels and in combination with currently available antineoplastic drugs.
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